Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Genmab    GMAB   DK0010272202

GENMAB

(GMAB)
  Report
Real-time Estimate Quote. Real-time Estimate CHI-X - 02/21 10:59:41 am
1686.75 DKK   -0.66%
03:21pGenmab Board of Directors Chairman to Step Down
GL
02/19GENMAB : 2019 Full Year Financial Results_Conference Call Slides
PU
02/19GENMAB : Compensation Report 2019
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Financials (DKK)
Sales 2020 5 107 M
EBIT 2020 1 232 M
Net income 2020 1 071 M
Finance 2020 12 827 M
Yield 2020 -
P/E ratio 2020 105x
P/E ratio 2021 44,3x
EV / Sales2020 19,2x
EV / Sales2021 13,5x
Capitalization 111 B
Chart GENMAB
Duration : Period :
Genmab Technical Analysis Chart | GMAB | DK0010272202 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 1 566,58  DKK
Last Close Price 1 705,00  DKK
Spread / Highest target 16,2%
Spread / Average Target -8,12%
Spread / Lowest Target -88,6%
Chart GENMAB
Duration : Period :
Genmab Technical Analysis Chart | GMAB | DK0010272202 | MarketScreener
Sector and Competitors
1st jan.Capitalization (M$)
GENMAB14.61%15 962
GILEAD SCIENCES3.11%84 765
VERTEX PHARMACEUTICALS12.49%63 547
REGENERON PHARMACEUTICALS6.30%43 450
WUXI APPTEC CO., LTD.20.50%25 998
BEIGENE, LTD.2.28%13 192